Page 143 - CW E-Magazine (24-9-2024)

Pharmaceuticals Hydrocarbons

RECOGNITION NO DISRUPTIONS
Wockhardt bags BIRAC innovator award for novel Numaligarh Refi nery continuing to export diesel

antibiotic to Bangladesh

State-run Oil India Ltd.’s (OIL’s)
Wockhardt has won the prestigious (CABP). Dr. Mahesh Patel, Chief sistance issues or lack comprehensive Chairman, Mr. Ranjit Rath, has said the
‘BIRAC Innovator Award 2024’ for its Scientifi c Offi cer – Drug Discovery coverage of respiratory pathogens. company is not facing any hindrances
groundbreaking antibiotic, Nafi thro- Research, accepted the award on behalf India accounts for 23% of the global in payments or the export of diesel to
mycin (Miqnaf). of Wockhardt’s Chairman, Dr. Habil pneumonia burden, with an estimated crisis-ridden Bangladesh.
Khorakiwala, at the ‘Global Bio-India 8-10-million CABP infections annually.
The award, presented by the Bio- 2024’ event in New Delhi. OIL’s subsidiary, Assam-based
technology Industry Research Assis- Nafi thromycin has completed phase Numaligarh Refi nery Ltd. (NRL), exports
tance Council (BIRAC), a Government Nafi thromycin, developed over 12 III clinical trials in India and awaits diesel to Bangladesh, where an interim
of India enterprise, recognises Wock- years, offers a 3-day oral treatment approval from the Drug Controller government has been formed after Prime
hardt’s research in developing the fi rst course for CABP, potentially reducing General of India (DCGI). It represents Minister Sheikh Hasina resigned and
multi-drug resistant pathogen active hospitalisations. The drug addresses the fi rst new macrolide drug globally fl ed the country following mass protests
respiratory antibiotic for Commu- a signifi cant medical need, as existing in 33 years for treating community recently. In a media briefi ng post the
nity-Acquired Bacterial Pneumonia treatments like azithromycin face re- respiratory infections. company’s annual general meeting,
Mr. Rath said that the letter of credit (LC)
REGULATORY ACTION mechanism is in place and there is no of movement...The India-Bangladesh sion plans are on track and are set to
USFDA cites manufacturing lapses at Zydus Life- “payment problem” regarding the export Friendship Pipeline, laid from Siliguri to be commissioned by December 2025.
of diesel to Bangladesh. Moreover, the Parbatipur in Bangladesh, is functioning NRL is increasing capacity at its refi -
sciences’ Jarod plant expansion plans for Numaligarh Refi nery smoothly. Absolutely no disruption. We nery from 6-mtpa to 9-mtpa. The refi -
have also not been impacted by the unrest are pushing diesel utilising that particular nery is also setting up a crude oil
in Bangladesh. pipeline,” he assured. import terminal at Paradip (Odisha) and
The US health regulator has pulled The USFDA said it inspected the holding do not conform to CGMP, your will lay a 1,640-km pipeline to trans-
up Zydus Lifesciences for manufactu- manufacturing facility from April 15 drug products are adulterated.” A warn- “I am very happy to report that there is Expansion plans port crude oil to its home base in the
ring lapses at its Gujarat-based plant. to 23, 2024. “This warning letter sum- ing letter is issued when the US health no disruption at all. There is no disruption Mr. Rath noted that NRL’s expan- Golaghat district of Assam.
In a warning letter to company’s Mana- marises signifi cant violations of current regulator fi nds that a manufacturer has
ging Director, Mr. Sharvil Patel, the good manufacturing practice (CGMP) signifi cantly violated its regulations. TRADE TRENDS
USFDA noted that the drug maker failed regulations for fi nished pharmaceuti- USFDA has sought a detailed reme- Nayara Energy records 14% rise in domestic fuel
to investigate contamination identifi ed cals,” it added. It further said, “Because diation plan from the drug fi rm with
in drug products at its Jarod-based plant your methods, facilities, or controls for timelines to address the fi ndings of the sales, exports drop
in Vadodara district. manufacturing, processing, packing, or contamination hazards risk assessment.
Nayara Energy, private fuel retailer, uphold the potential to fuel India’s domestic demand, surplus products were
Akums gets patent for room temperature stable oral posted a 14.3% rise in fuel sales for the growth. exported by Nayara Energy – about 1.36-mt
(28% of total sales), including jet fuel,
suspension second quarter of the 2024 calendar year, Retail diesel sales rose 14% to 2.08-mt diesel and others, during April-June
while exports dropped as the fi rm met
rising local demand for fuel. in April-June from 1.82-mt a year 2024. Given the robust demand in the
Akums Drugs and Pharmaceuti- blood disorder, leads to severe health requires refrigeration between 2-8°C. back, while institutional business’ year- Indian market, petrol exports have
cals Ltd., a leading Contract Develop- complications such as anaemia, fre- “The new oral suspension remains “In the April-June quarter, Nayara on-year growth was 23%, Nayara said. decreased from 36% of total petrol
ment and Manufacturing Organization quent pain episodes and other debili- stable at room temperature, providing sold 75% of all diesel it produced at Similarly, retail petrol sales grew 14.7% sales in April-June 2023 to 21% in
(CDMO), has been awarded a patent tating symptoms, affecting millions a practical solution for widespread its Vadinar oil refi nery in Gujarat in to 0.916-mt in the second quarter com- April-June 2024.
for its room temperature stable oral worldwide especially in India and distribution, particularly in the tribal the local market and 60% of its petrol pared to 0.809-mt a year back. The fi rm
suspension of hydroxyurea – a break- Africa. areas with limited access to cold stor- production locally,” Nayara said. Over said over the last few years, it has strate- Nayara exported 1.36-mt of fuel in
through formulation aimed at managing age facilities,” the company said. The the past few years, Nayara Energy gically expanded its network, with April-June this year, of which 0.65-mt
Sickle Cell Disease (SCD). The company said its new for- patented formulation will also come at has steadily built its domestic busi- almost 35% of its fuel stations situated in was diesel. Its natural export markets are
mulation offers a key advantage over fraction of the cost of imported hydroxy- ness while expanding its fuel retailing Tier 3, 4 and 5 towns, enabling mobility in Africa, Southeast Asia and the Middle
Sickle Cell Disease, a genetic traditional hydroxyurea solution that urea solution, it added. network to underserved markets that and spurring commerce. After fulfi lling East.

142 Chemical Weekly September 24, 2024 Chemical Weekly September 24, 2024 143

Contents Index to Advertisers Index to Products Advertised